NewEdge Wealth’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.4M | Buy |
45,638
+7,021
| +18% | +$524K | 0.05% | 272 |
|
|
2025
Q1 | $2.84M | Buy |
38,617
+1,427
| +4% | +$105K | 0.05% | 280 |
|
|
2024
Q4 | $2.44M | Buy |
37,190
+5,797
| +18% | +$380K | 0.04% | 308 |
|
|
2024
Q3 | $2.45M | Buy |
31,393
+2,031
| +7% | +$158K | 0.04% | 314 |
|
|
2024
Q2 | $2.29M | Buy |
29,362
+187
| +0.6% | +$14.6K | 0.05% | 304 |
|
|
2024
Q1 | $2.21M | Sell |
29,175
-2,389
| -8% | -$181K | 0.05% | 312 |
|
|
2023
Q4 | $2.13M | Buy |
31,564
+2,530
| +9% | +$170K | 0.05% | 288 |
|
|
2023
Q3 | $1.97M | Buy |
29,034
+2,775
| +11% | +$188K | 0.06% | 260 |
|
|
2023
Q2 | $1.88M | Sell |
26,259
-2,756
| -9% | -$197K | 0.06% | 260 |
|
|
2023
Q1 | $2.01M | Sell |
29,015
-906
| -3% | -$62.9K | 0.08% | 222 |
|
|
2022
Q4 | $2.03M | Buy |
29,921
+1,450
| +5% | +$98.3K | 0.09% | 210 |
|
|
2022
Q3 | $1.56M | Buy |
28,471
+4,630
| +19% | +$254K | 0.07% | 222 |
|
|
2022
Q2 | $1.58M | Buy |
23,841
+17,330
| +266% | +$1.14M | 0.07% | 219 |
|
|
2022
Q1 | $432K | Sell |
6,511
-17,131
| -72% | -$1.14M | 0.02% | 322 |
|
|
2021
Q4 | $1.38M | Sell |
23,642
-28,036
| -54% | -$1.63M | 0.06% | 206 |
|
|
2021
Q3 | $3.1M | Buy |
51,678
+45,891
| +793% | +$2.76M | 0.18% | 106 |
|
|
2021
Q2 | $347K | Buy |
5,787
+896
| +18% | +$53.7K | 0.03% | 233 |
|
|
2021
Q1 | $243K | Buy |
+4,891
| New | +$243K | 0.02% | 272 |
|